News dal mondo
07
Apr
Trump tariff order pushes onshore drug manufacturing longer term: analysts
Leerink Partners analysts see no near-term material changes to U.S. onshoring narrative, given Trump’s executive order late last week on pharmaceutical imports....[PharmaManufacturing]
Mag
AIFA - Sistema informatico Workflow Officine Materie Prime - aggiornamento
Tutte le officine farmaceutiche di produzione e/o importazione materie prime sono tenute a trasmettere...
30
AIFA pubblica il Terzo Position Paper sui farmaci biosimilari
È online il terzo Position Paper AIFA sui farmaci biosimilari. L’aggiornamento del documento...
29
US GDUFA IV Talks Reach Tentative Agreement; America First Application Fee Waiver Added
US FDA GDUFA Reauthorization performance goals and program enhancements Riscal years 2023-2027 - Meeting...
28
Sun Pharma compra Organon
Sun Pharmaceutical Industries ha firmato un accordo definitivo per acquisire Organon &...
le ultime news
07 Mag
30 Apr
29 Apr
28 Apr
27 Apr
US QMM: Participants scored well on commitment to quality, lower on advanced manufacturing
23 Apr
Top Drugs at Risk of Supply Shortages
Regulatory considerations for pharmaceutical excipient selection
21 Apr
TGA clarifies therapeutic goods are unaffected by chemical production and import ban
1 2>>>
